Author/Creator: Procopio, G - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Procopio, G

1. Adjuvant treatment of high-risk renal cell carcinoma: the jury is still out. (1st September 2018)

Authors:: Procopio, G; Sepe, P; Verzoni, E; Pignata, S; Bamias, A
Journal:: Annals of oncology
Issue:: Volume 29:Number 10(2018)
Page Start:: 2030
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. 1211PHyperprogression during immuno-checkpoint inhibitors (ICIs): A clinically significant problem?. (23rd October 2018)

Authors:: Farè, E; Sdao, S; Damian, S; Cresta, S; Del Vecchio, M; Di Bartolomeo, M; Di Guardo, L A; Duca, M; Indini, A; Necchi, A; Niger, M; Prisciandaro, M; Procopio, G; Raggi, D; Verzoni, E; Pruneri, G; Di Nicola, M; de Braud, F G M
Journal:: Annals of oncology
Issue:: Volume 29(2018)Supplement 8
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. 880PSubgroups analysis and circulating biomarkers evaluation of RESORT trial: A randomized phase II study in metastatic renal cell carcinoma (mRCC) patients (pts) to evaluate the efficacy of sorafenib after metastasectomy. (23rd October 2018)

Authors:: Procopio, G; Cognetti, F; Miceli, R; Milella, M; Mosca, A; Chiuri, V E; Bearz, A; Morelli, F; Ortega, C; Atzori, F; Passalacqua, R; Ratta, R; de Braud, F G M; Cappelletti, V; Verzoni, E
Journal:: Annals of oncology
Issue:: Volume 29(2018)Supplement 8
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. 884PReal-world effectiveness of pazopanib in patients with intermediate prognostic risk advanced renal cell carcinoma (PRINCIPAL study). (23rd October 2018)

Authors:: Procopio, G; Bamias, A; Schmidinger, M; Hawkins, R; Rodriguez Sanchez, A; Vazquez, S; Srihari, N; Kalofonos, H; Bono, P; Pisal, C; Hirschberg, Y; Dezzani, L; Ahmad, Q; Suarez Rodriguez, C; Jonasch, E
Journal:: Annals of oncology
Issue:: Volume 29(2018)Supplement 8
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. 882PPotent natural killer (NK) and myeloid blood cell remodeling by cabozantinib (Cabo) in pre-treated metastatic renal cell carcinoma (mRCC) patients (pts). (23rd October 2018)

Authors:: Verzoni, E; Ferro, S; Procopio, G; Cova, A; Ratta, R; Raimondi, A; Sepe, P; Squarcina, P; Lalli, L; Huber, V; Rinchai, D; Bedognetti, D; Rivoltini, L
Journal:: Annals of oncology
Issue:: Volume 29(2018)Supplement 8
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗